Vijayakrishna Gadi, MD, PhD, and Megan Kruse, MD, discuss the clinical benefits reported with neratinib for the treatment of patients with HER2-positive early breast cancer.

Related Keywords

Vijayakrishna Gadi , Megan Kruse , , Evolving Adjuvant Treatments , Early Breast Cancer , Benefits With Neratinib , Early Breast ,